Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-03

Clinical Trial Update: Experimental Medication For the Treatment of Generalized Anxiety Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating an experimental medication for generalized anxiety disorder has completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Experimental medication

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Anxiety Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-10-03